- Colorectal, or bowel, cancer is the third most common cancer worldwide, and the second leading cause of cancer deaths.
- Treatments include surgery, radiotherapy, chemotherapy, or immunotherapy, but the efficacy of treatment depends on the type of bowel cancer the person has.
- A phase 1 trial has found that two monoclonal antibodies could be effective against a common form of colorectal cancer that has, historically, not responded to immunotherapy.
- These findings could be a first step towards more…
Read the full article here